Enfusion, Inc.
ENFN US
ENFN USEnfusion, Inc.
United States Composite9.49
Company Description
- CEO
- Mr. Oleg Movchan
- Full Time Employees
- 1,102
- Sector
- Technology
- Industry
- Software—Application
- Address
- 125 South Clark Street Chicago IL United States 60603
- CIK
- 0001868912
- Website
- www.enfusion.com
- Business
- Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.
Company News
Enfusion Announces Date of First Quarter 2024 Results
Piper Sandler Reaffirms Their Hold Rating on Enfusion (ENFN)
Will Enfusion (ENFN) Grow Revenue And Expand Margins In The Future?
Enfusion’s Growth Strategy Met with Sell Rating Amid Market and Strategic Challenges
Analysts’ Opinions Are Mixed on These Technology Stocks: GoDaddy (GDDY) and Enfusion (ENFN)
Kayne Anderson Strengthens Investment Operations After Successful Platform Migration to Enfusion
Enfusion (ENFN) Gets a Hold from Piper Sandler
Stifel Nicolaus Keeps Their Buy Rating on Enfusion (ENFN)
Analysts Have Conflicting Sentiments on These Technology Companies: Marvell (MRVL) and Enfusion (ENFN)
Enfusion (ENFN) Gets a Buy from William Blair
Enfusion, Inc. (NYSE:ENFN) Q4 2023 Earnings Call Transcript
Analysts Offer Insights on Technology Companies: Repay Holdings (RPAY), Instructure Holdings (INST) and Enfusion (ENFN)
Q4 2023 Enfusion Inc Earnings Call
William Blair Reaffirms Their Buy Rating on Enfusion (ENFN)
Enfusion, Inc. (ENFN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Enfusion, Inc. (ENFN) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Enfusion, Inc. (ENFN) Lags Q4 Earnings Estimates
Enfusion, Inc. (ENFN) Lags Q4 Earnings Estimates
Enfusion Announces Fourth Quarter 2023 Results and Full Year 2023 Results
Box (BOX) Q4 Earnings Beat Estimates